TY - JOUR
T1 - How concerns and experiences with medical malpractice affect dermatopathologists’ perceptions of their diagnostic practices when interpreting cutaneous melanocytic lesions
AU - Carney, Patricia A.
AU - Frederick, Paul D.
AU - Reisch, Lisa M.
AU - Knezevich, Stevan
AU - Piepkorn, Michael W.
AU - Barnhill, Raymond L.
AU - Elder, David E.
AU - Geller, Berta M.
AU - Titus, Linda
AU - Weinstock, Martin A.
AU - Nelson, Heidi D.
AU - Elmore, Joann G.
N1 - Funding Information:
Supported by the National Cancer Institute (R01 CA151306). The content is solely the responsibility of the authors and does not necessarily represent the views of the National Cancer Institute or the National Institutes of Health.
Publisher Copyright:
© 2015 American Academy of Dermatology, Inc.
PY - 2016/2/1
Y1 - 2016/2/1
N2 - Objective We sought to identify characteristics associated with past malpractice lawsuits and how malpractice concerns may affect interpretive practices. Methods We surveyed 207 of 301 (68.8%) eligible dermatopathologists who interpret melanocytic skin lesions in 10 states. The survey assessed dermatopathologists’ demographic and clinical practice characteristics, perceptions of how medical malpractice concerns could influence their interpretive practices, and past malpractice lawsuits. Results Of dermatopathologists, 33% reported past malpractice experiences. Factors associated with being sued included older age (57 vs 48 years, P <.001), lack of board certification or fellowship training in dermatopathology (76.5% vs 53.2%, P =.001), and greater number of years interpreting melanocytic lesions (>20 years: 52.9% vs 20.1%, P <.001). Of participants, 64% reported being moderately or extremely confident in their melanocytic interpretations. Although most dermatopathologists believed that malpractice concerns increased their likelihood of ordering specialized pathology tests, obtaining recuts, and seeking a second opinion, none of these practices were associated with past malpractice. Most dermatopathologists reported concerns about potential harms to patients that may result from their assessments of melanocytic lesions. Limitations Limitations of this study include lack of validation of and details about the malpractice suits experienced by participating dermatopathologists. In addition, the study assessed perceptions of practice rather than actual practices that might be associated with malpractice incidents. Conclusions Most dermatopathologists reported apprehension about how malpractice affects their clinical practice and are concerned about patient safety irrespective of whether they had actually experienced a medical malpractice suit.
AB - Objective We sought to identify characteristics associated with past malpractice lawsuits and how malpractice concerns may affect interpretive practices. Methods We surveyed 207 of 301 (68.8%) eligible dermatopathologists who interpret melanocytic skin lesions in 10 states. The survey assessed dermatopathologists’ demographic and clinical practice characteristics, perceptions of how medical malpractice concerns could influence their interpretive practices, and past malpractice lawsuits. Results Of dermatopathologists, 33% reported past malpractice experiences. Factors associated with being sued included older age (57 vs 48 years, P <.001), lack of board certification or fellowship training in dermatopathology (76.5% vs 53.2%, P =.001), and greater number of years interpreting melanocytic lesions (>20 years: 52.9% vs 20.1%, P <.001). Of participants, 64% reported being moderately or extremely confident in their melanocytic interpretations. Although most dermatopathologists believed that malpractice concerns increased their likelihood of ordering specialized pathology tests, obtaining recuts, and seeking a second opinion, none of these practices were associated with past malpractice. Most dermatopathologists reported concerns about potential harms to patients that may result from their assessments of melanocytic lesions. Limitations Limitations of this study include lack of validation of and details about the malpractice suits experienced by participating dermatopathologists. In addition, the study assessed perceptions of practice rather than actual practices that might be associated with malpractice incidents. Conclusions Most dermatopathologists reported apprehension about how malpractice affects their clinical practice and are concerned about patient safety irrespective of whether they had actually experienced a medical malpractice suit.
KW - additional histology testing
KW - clinical interpretation
KW - defensive clinical practice
KW - dermatopathology
KW - medical malpractice
KW - melanoma
UR - http://www.scopus.com/inward/record.url?scp=84964922646&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84964922646&partnerID=8YFLogxK
U2 - 10.1016/j.jaad.2015.09.037
DO - 10.1016/j.jaad.2015.09.037
M3 - Article
C2 - 26559597
AN - SCOPUS:84964922646
SN - 0190-9622
VL - 74
SP - 317-324.e8
JO - Journal of the American Academy of Dermatology
JF - Journal of the American Academy of Dermatology
IS - 2
ER -